Anti-Kappa recognizes surface immunoglobulin on normal and neoplastic B-cells, and has been indicated as a potential aid in the identification of leukemias, plasmacytomas, and certain non-Hodgkins lymphomas, where the expression of a single light chain class is restricted. The determination of light chain ratio is critical in evaluating B-cell neoplasms, as the majority of B-cell lymphomas express either kappa or lambda light chains, while a mixture of kappa and lambda is characteristic of reactive proliferations. In paraffin-embedded tissue, Anti-Kappa displays strong staining of kappa-positive plasma cells, as well as cells that have absorbed exogenous immunoglobulins.

Bray M, et al. Am J Clin Pathol. 1983; 80:526-8. Ashton-Key M, et al. Histopathology. 1996; 29:525-31. Kurtin PJ, et al. Am J Clin Pathol. 1999; 112:319-29. Falini B, et al. J Histochem Cytochem. 1982; 30:21-6. Marshall-Taylor CE, et al. Appl Immunohistochem Mol Morphol. 2002; 10:258-62. Sobol RE, et al. Clin Immunol Immunopathol. 1982; 24:139 -44. Samoszuk MK, et al. Diagn Immunol. 1985; 3:133-8. Abbondanzo SL, et al. Ann Diagn Pathol. 1999; 3:318-27.